5-amino-1mq

Most metabolic research targets hormone receptors. 5-Amino-1MQ targets an enzyme. Specifically, it inhibits NNMT — nicotinamide N-methyltransferase — a cytoplasmic enzyme that methylates nicotinamide using S-adenosylmethionine as the methyl donor. That reaction consumes two things simultaneously: nicotinamide (a NAD+ precursor) and SAM (the universal methyl donor for DNA and histone methylation). Inhibit NNMT and both accumulate. CAS: 42464-98-2. MW 231.3 Da. Cell-permeable small molecule.

Why This Target

NNMT expression is elevated in obese white adipose tissue. Preclinical work — including research from the Brenner lab — suggests NNMT inhibition shifts adipocyte metabolism toward increased energy expenditure. Not by directly stimulating thermogenesis, but by altering the metabolic program of the cell. The NAD+ increase feeds into SIRT1, which downstream affects mitochondrial biogenesis and fatty acid oxidation. The SAM conservation effect also alters methylation-dependent gene regulation.

The honest answer is that the full downstream biology of NNMT inhibition isn't completely characterized. That's part of what makes it interesting — it sits at the intersection of NAD+ metabolism and epigenetic regulation, two active enough fields that the implications keep expanding. For researchers working on adipose tissue metabolism, NAD+ biology, or the epigenetics of metabolic disease, this is a tool that reaches all three at once.

Specifications

Storage: Room temperature, away from moisture and direct light. Lyophilized form: −20°C.

Quality: Shipped to a ≥98% supplier batch specification; selected lots are independently tested by Janoshik Analytical (HPLC + mass spectrometry; 99.3% average purity across published reports), searchable by batch code at certapeptides.com/verify. EU-based QC under CERTALAB S.R.L.

For research purposes only. Not for human consumption.